CD200

From WikiMD's WELLNESSPEDIA

CD200 is a type of protein that in humans is encoded by the CD200 gene. It is also known as OX-2 membrane glycoprotein. CD200 is a member of the immunoglobulin superfamily and is involved in the regulation of immune responses.

Structure of the CD200 protein.

Structure[edit]

CD200 is a type 1 membrane glycoprotein, which contains two immunoglobulin domains. The extracellular domain of CD200 is responsible for its immunoregulatory function. It interacts with the CD200 receptor (CD200R) on the surface of certain immune cells.

Function[edit]

CD200 has been shown to play a role in the regulation of macrophage activation and function. It does this by interacting with its receptor, CD200R, which is primarily expressed on the surface of myeloid lineage cells. This interaction leads to the suppression of T cell responses and provides a mechanism for the control of inflammatory responses.

In addition to its role in controlling immune responses, CD200 has also been implicated in neuroprotection. It is expressed in various tissues including neurons, endothelial cells, and in certain tumors.

Clinical significance[edit]

Alterations in the expression of CD200 have been associated with a variety of diseases. For example, increased expression of CD200 has been observed in certain types of cancer, including melanoma, ovarian cancer, and certain types of leukemia. This overexpression may contribute to the immune evasion of these tumors.

Conversely, decreased expression of CD200 has been associated with autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. In these conditions, the lack of CD200 expression may contribute to the overactive immune response seen in these diseases.

Research[edit]

Research is ongoing to develop therapeutic strategies that target CD200 and its receptor. These strategies could potentially be used to treat a variety of conditions, from autoimmune diseases to cancer.


See also[edit]

References[edit]





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.